| Literature DB >> 10888336 |
L Chan1, T Stefanac, N Turcotte, Z Hu, Y Chen, J Bédard, S May, H Jin.
Abstract
Following the identification of first pass metabolism issues with our recently described anti-HCMV compounds, the naphthyridines and isoquinolines, we have designed a class of novel metabolically stable and orally bioavailable anti-HCMV agents, the dihydroisoquinolines.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10888336 DOI： 10.1016/s0960-894x(00)00265-1
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823